The Gut-Peritoneum Axis in Peritoneal Dialysis and Peritoneal Fibrosis

被引:8
作者
Stepanova, Natalia [1 ,2 ]
机构
[1] Natl Acad Med Sci Ukraine, Dept Nephrol & Dialysis, State Inst Inst Nephrol, Kiev, Ukraine
[2] Natl Acad Med Sci Ukraine, Dept Nephrol & Dialysis, State Inst Inst Nephrol, 17 V Degtyarivska, UA-04050 Kiev, Ukraine
关键词
P-CRESYL SULFATE; STAPHYLOCOCCUS-AUREUS; OXIDATIVE STRESS; INDOXYL SULFATE; MICROBIOTA; MEMBRANE; EFFLUENT; BACTERIA; ACTIVATION; FAILURE;
D O I
10.1016/j.xkme.2023.100645
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Peritoneal fibrosis is an important cause of peritoneal dialysis (PD) discontinuation worldwide and is associated with high morbidity and mortality rate. Although the era of metagenomics has provided new insights into the interactions between the gut microbiota and fibrosis in various organs and tissues, its role in peritoneal fibrosis has rarely been discussed. This review provides a scientific rationale and points out the potential role of gut microbiota in peritoneal fibrosis. In addition, the interaction between the gut, circulatory, and peritoneal microbiota is highlighted, with an emphasis on the relationship to PD outcomes. More research is needed to elucidate the mechanisms underlying the role of gut microbiota in peritoneal fibrosis and potentially unveil new target options for the management of PD technique failure.(c) 2023 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:9
相关论文
共 87 条
[81]   Pathophysiological Changes to the Peritoneal Membrane during PD-Related Peritonitis: The Role of Mesothelial Cells [J].
Yung, Susan ;
Chan, Tak Mao .
MEDIATORS OF INFLAMMATION, 2012, 2012
[82]   Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients [J].
Zhang, Lei ;
Xie, Feifei ;
Tang, Haie ;
Zhang, Xinrong ;
Hu, Jianxia ;
Zhong, Xiaohong ;
Gong, Nirong ;
Lai, Yunshi ;
Zhou, Miaomiao ;
Tian, Jianwei ;
Zhou, Zhanmei ;
Xie, Liling ;
Hu, Zheng ;
Zhu, Fengxin ;
Jiang, Jianping ;
Nie, Jing .
TRANSLATIONAL RESEARCH, 2022, 240 :50-63
[83]   The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease [J].
Zhang, Qing ;
Zhang, Yanmei ;
Zeng, Lu ;
Chen, Guowei ;
Zhang, La ;
Liu, Meifang ;
Sheng, Hongqin ;
Hu, Xiaoxuan ;
Su, Jingxu ;
Zhang, Duo ;
Lu, Fuhua ;
Liu, Xusheng ;
Zhang, Lei .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[84]   Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review [J].
Zhao, Jin ;
Ning, Xiaoxuan ;
Liu, Baojian ;
Dong, Ruijuan ;
Bai, Ming ;
Sun, Shiren .
RENAL FAILURE, 2021, 43 (01) :102-112
[85]   Exploration of the correlation between intestinal flora and Escherichia coli peritoneal dialysis-related peritonitis [J].
Zhou, Jun ;
Yang, Cuishun ;
Lei, Wenjuan ;
Yang, Zhen ;
Chen, Jianmei ;
Lin, Hua ;
Li, Qingtian ;
Yuan, Wanqiong .
BMC NEPHROLOGY, 2022, 23 (01)
[86]  
Zhou LS, 2015, INT J CLIN EXP MED, V8, P20424
[87]   Preventing peritoneal membrane fibrosis in peritoneal dialysis patients [J].
Zhou, Qin ;
Bajo, M-Auxiliadora ;
del Peso, Gloria ;
Yu, Xueqing ;
Selgas, Rafael .
KIDNEY INTERNATIONAL, 2016, 90 (03) :515-524